On average, it takes more than 10 years to develop a drug and costs more than $1.3 billion. Over 70% of drug R&D costs are spent on clinical development, yet the success rate from phase I to approval is only around 10%. At Evinova, a health tech business unit, we are on a mission to increase clinical trial success rates by 20%, accelerate clinical development timelines by 36 months, and reduce study costs by 50% by leveraging state-of-the-art AI and Machine Learning.
If you are a solid coder with hands‑on experience developing AI and ML solutions, strong understanding of modern deep learning, robust AWS skills, and a voracious learner, then you could be a fantastic fit for our team.
Talent with ambition to grow into leadership roles will be a key differentiator for successful candidates.
We are seeking a highly skilled and innovative Principal AI Engineer to design and implement advanced machine learning models that...